Cargando…

Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA

BACKGROUND: To achieve natural-looking outcomes when treating dynamic lines with botulinum toxin (BoNT), retreatment must be timed such that the patient maintains a relatively constant aesthetic outcome. Although first-generation BoNT products require retreatment with 3- to 4-month frequency to avoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dover, Jeffrey S., Solish, Nowell, Gross, Todd M., Gallagher, Conor J., Brown, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461716/ https://www.ncbi.nlm.nih.gov/pubmed/37384899 http://dx.doi.org/10.1097/DSS.0000000000003852

Ejemplares similares

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2022)

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
por: Glogau, Richard, et al.
Publicado: (2021)

Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
por: Solish, Nowell, et al.
Publicado: (2022)

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
por: Gallagher, Conor J., et al.
Publicado: (2023)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
por: Fabi, Sabrina G., et al.
Publicado: (2021)

Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study
por: Dover, Jeffrey S., et al.
Publicado: (2023)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
por: Green, Jeremy B., et al.
Publicado: (2021)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
por: Carruthers, Jean D., et al.
Publicado: (2020)

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
por: Cohen, Joel L., et al.
Publicado: (2021)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study
por: Jankovic, Joseph, et al.
Publicado: (2018)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data
por: Solish, Nowell, et al.
Publicado: (2022)

Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Carruthers, Jean, et al.
Publicado: (2023)

Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
por: Carruthers, Alastair, et al.
Publicado: (2016)

Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis
por: Bertucci, Vince, et al.
Publicado: (2022)

The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks
por: de Sanctis Pecora, Carla, et al.
Publicado: (2021)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies
por: Beer, Kenneth R., et al.
Publicado: (2019)

The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks [Corrigendum]
Publicado: (2021)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022)

Glabellar vertical line as a reference goal for anteroposterior maxillary position
por: Carruitero, Marcos J., et al.
Publicado: (2019)

Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

A Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines
por: Schlessinger, Joel, et al.
Publicado: (2021)

Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)

Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
por: Stengel, Gabriele, et al.
Publicado: (2011)

A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines
por: Punga, Anna Rostedt, et al.
Publicado: (2016)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Glabellar Presentation, Its Incidence and Termination
por: Mudaliar, A. L.
Publicado: (1934)

Glabellar flap technique in oculoplastic surgery
por: Balchev, Georgi, et al.
Publicado: (2022)

Glabellar and auricular leukemia cutis in CLL
por: Steinman, Bradley, et al.
Publicado: (2022)

OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review
por: De Boulle, Koenraad, et al.
Publicado: (2020)

Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow’s Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study
por: Yi, Dong-Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uforvlqb2bk71k8echnppp9u43